About this trial
The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,
normally presented singleton fetus, intact fetal membranes, and who are free of
Disqualifiers
abnormal placental position,
ASA grade>II
marked obesity,
allergy or contraindications to the used drugs,
Trial design
Parallel
Treatments tested in this trial
Epidural Catheter with bupivacaine
Deviceepidural injection of plain Bup
Epidural with dural puncture
Devicethe dura is punctured by a 26-G spinal needle using the needle-through-needle technique, and is withdrawn after confirmation of free-flowing cerebrospinal fluid,
Dexmedetomidine 0.4 added
DrugDexmedetomidine 0.4 added
Dexmedetomidine 0.6 added
DrugDexmedetomidine 0.6 added
Treatment groups
Trial outcomes
Primary outcomes
Total dose of bupivacaine
Total dose of bupivacaine administered
Secondary outcomes
Labor pain
Labour pain measured by Visual analogue
Motor block
Motor block measured by bromage scsle
Delivery type
Delivery type spontaneous or instrument
Maternal satisfaction
Satisfied or not
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.